Christopher Pack, Ph.D.
310
page-template,page-template-full_width,page-template-full_width-php,page,page-id-310,qode-social-login-1.1.3,qode-restaurant-1.1.1,stockholm-core-1.1,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Christopher Pack, Ph.D.

Director, Preclinical Studies

Dr. Pack has over 20 years of training and expertise in vaccine design and CD8+ T cell biology. He received his Ph.D. from the University of Tennessee where he studied neonatal vaccine design against Herpes Simplex Virus-1 in the laboratory of Dr. Barry T. Rouse. After earning his doctorate degree, Dr. Pack:

  • Studied CD8+ T cell memory formation during persistent oncogenic viral infection at Emory University in the lab of Dr. Aron Lukacher.
  • Joined Metaclipse in 2012 to lay the preclinical groundwork for the TNBC approach
  • Has served as the Principal Investigator (PI) for the phase I SBIR grant focused on proof-of-concept studies to treat TNBC and the Co-PI for the phase II product development grant
  • Has led the preclinical research division at Metaclipse Therapeutics